Home Care Improvement Intervention for Heart Failure
(I-TRANSFER-HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new method to help people with heart failure transition smoothly from hospital to home care. Named I-TRANSFER-HF, it combines early visits from home health nurses with outpatient medical appointments to determine if it can reduce hospital readmissions within 30 days. The study aims to assess the effectiveness and practicality of this plan in real-life settings. Suitable participants are those currently hospitalized for heart failure who will receive home health care after discharge. As an unphased trial, this study provides a unique opportunity to contribute to innovative care strategies that could enhance transitions from hospital to home.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on improving care transitions rather than changing medication regimens.
What prior data suggests that I-TRANSFER-HF is safe for heart failure patients?
Research shows that the I-TRANSFER-HF treatment aims to ease the transition from hospital to home for people with heart failure. Nurses visit patients at home early and schedule prompt follow-up medical appointments.
Specific data on the safety of I-TRANSFER-HF is not available because it focuses on better care organization, not a new drug or device. Generally, programs like this aim to improve care delivery and are considered low-risk. Since the study evaluates I-TRANSFER-HF in everyday settings, it suggests minimal safety concerns.
The trial setup indicates likely safety, as it employs existing healthcare practices rather than introducing new medical treatments.12345Why are researchers excited about this trial?
Researchers are excited about the I-TRANSFER-HF intervention because it offers a novel approach to managing heart failure at home. Unlike traditional treatments that primarily involve regular hospital visits and medication management, I-TRANSFER-HF leverages digital health tools and personalized care plans to improve patient outcomes right from their homes. This innovative method aims to enhance patient engagement and adherence to treatment protocols by providing real-time health monitoring and tailored support. By shifting the focus to home-based care, I-TRANSFER-HF may reduce hospital readmissions and improve the quality of life for heart failure patients, making it a promising development in heart failure management.
What evidence suggests that I-TRANSFER-HF is effective for improving the hospital-to-home transition for heart failure patients?
Research has shown that early visits from home health nurses and timely follow-up doctor appointments can reduce hospital readmissions for heart failure patients. In this trial, the I-TRANSFER-HF program, which participants may receive, combines these steps to ease the transition from hospital to home. Studies have found that similar programs lower the chances of patients returning to the hospital within 30 days. By improving coordination between hospitals and home care services, I-TRANSFER-HF aims to keep heart failure patients healthier at home. Early results suggest this approach could be more effective than standard care, another arm of this trial, in preventing early readmissions.13456
Who Is on the Research Team?
Madeline R Sterling, MD, MPH, MS
Principal Investigator
Weill Medical College of Cornell University
Are You a Good Fit for This Trial?
This trial is for adults hospitalized with heart failure transitioning from certain hospitals to home health care (HHC) services. It includes healthcare professionals involved in this transition process at participating hospital-HHC pairs. Excluded are patients discharged elsewhere, on dialysis, or with left ventricular devices.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of I-TRANSFER-HF, combining early home health nurse visits and outpatient medical appointments
Follow-up
Participants are monitored for safety and effectiveness after intervention
What Are the Treatments Tested in This Trial?
Interventions
- I-TRANSFER-HF
Find a Clinic Near You
Who Is Running the Clinical Trial?
Weill Medical College of Cornell University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Johns Hopkins University
Collaborator
University of Colorado, Denver
Collaborator
NYU Langone Health
Collaborator
University of California, San Diego
Collaborator